Pharm-Olam International is proud to announce that it has been named a finalist in the 2016 Scrip Awards in the category of Best Contract Research Organization – Full-Service Providers. The nomination comes as a result of Pharm-Olam’s strong showing against a competitive field of other midsize and global CRO competitors.
For the category of Best Contract Research Organization – Full-Service Providers, entries were evaluated against a number of criteria related to innovation and sponsor satisfaction. Now in its 12th year, the Scrip Awards selected Pharm-Olam’s nomination based on responses to questions about its Organizational Strengths, Tendency to Meet or Exceed Sponsor Expectations, Innovations in Patient Recruitment Strategy, Ability to Streamline Data Collection and Reporting, and Ability to Optimize Trial Timelines and Increase Transparency.
“As a 22-year old multi-national full service provider that has managed trials’ in over 65 countries, we have continuously strived to develop unique patient recruitment strategies, introduce flexible, transparent processes and maintain productive relationships with sponsor teams and investigator sites,” said Sanjiv Suri, Pharm-Olam’s Chief Executive Officer. Mr. Suri added, “Like our other achievements this year, these awards validate our purpose—Helping to Create a Healthier World™. Our goal is to allow sponsors to make confident decisions about their development programs. We are humbled to have this recognition from Informa and the 2016 Scrip Awards.”
About the Scrip Awards
The Scrip Awards are administered by an independent judging panel comprised of independent, senior industry experts from around the world. Judges are selected for their knowledge, objectivity and credibility. The judges are then assigned to review categories most relevant to their expertise, and each category is reviewed by at least three judges. The Scrip Awards are sponsored by multinational publishing and events company Informa plc.
For more information about the Scrip Awards, please visit www.ScripAwards.com.
About Pharm-Olam International Group
Pharm-Olam International is a multinational Contract Research Organization (CRO) offering comprehensive clinical research services to the pharmaceutical, biotechnology and medical device industries. From Phase I to Phase IV, Pharm-Olam focuses on delivering the highest quality data, achieving targeted enrollment and meeting projected timelines, making clinical research as Easy As I, II, III, IV™. For further information about Pharm-Olam, please visit www.Pharm-Olam.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160927005250/en/Business Wire
Last updated on: 27/09/2016
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.